Trials / Completed
CompletedNCT00511732
18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes
A Randomized, Double-blind, Controlled, Stepwise Titration Study to Evaluate Dose Response to Prandial Administration of Inhaled Technosphere/Insulin or Technosphere in Patients With Type 2 Diabetes Mellitus Who Are Sub-optimally Treated
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 227 (actual)
- Sponsor
- Mannkind Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Designed to evaluate dose response of force-titrated prandial administration of TI as compared to placebo (TP) in subjects with Type 2 diabetes who were suboptimally controlled
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Technosphere Insulin | Technosphere Insulin Inhalation Powder |
| DRUG | Technosphere Placebo | Technosphere Inhalation Powder |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2005-08-01
- Completion
- 2007-08-01
- First posted
- 2007-08-06
- Last updated
- 2012-04-30
Source: ClinicalTrials.gov record NCT00511732. Inclusion in this directory is not an endorsement.